Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Other Working Capital Changes (2012 - 2026)

Precigen (PGEN) posted quarterly Other Working Capital Changes of -$107000.0 for Q1 2026, down 105.14% quarter-over-quarter from $2.1 million in Q4 2025.

Analysis

Precigen (PGEN) Other Working Capital Changes (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Other Working Capital Changes for 15 consecutive years, with -$107000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Working Capital Changes changed N/A year-over-year to -$107000.0; the TTM figure through Mar 2026 stood at $27000.0 (up 217.39% YoY), while the FY2025 annual figure was $134000.0, up 343.64% from the prior year.
  • Other Working Capital Changes eased to -$107000.0 in Q1 2026 per PGEN's latest filing, from $2.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.1 million in Q2 2022 and bottomed at -$2.1 million in Q1 2022.
  • Historically, Other Working Capital Changes has averaged -$191750.0 across 5 years, with a median of -$78500.0 in 2023.
  • Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 2010.71% — and 2025, when it surged 41540.0%.
  • Precigen's Other Working Capital Changes stood at -$28000.0 in 2022, then plunged by 2010.71% to -$591000.0 in 2023, then soared by 100.85% to $5000.0 in 2024, then soared by 41540.0% to $2.1 million in 2025, then plunged by 105.14% to -$107000.0 in 2026.
  • Business Quant data shows PGEN's Other Working Capital Changes at -$107000.0 in Q1 2026, $2.1 million in Q4 2025, and -$1.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -109,000.00
Jun 30, 2026 -109,000.00
Mar 31, 2026 562,000.00
Mar 31, 2026 562,000.00
Dec 31, 2025 -828,000.00
Dec 31, 2025 -828,000.00
Sep 30, 2025 1.87 Mn
Sep 30, 2025 1.87 Mn
Jun 30, 2025 -815,000.00
Jun 30, 2025 -815,000.00
Mar 31, 2025 -95,000.00
Mar 31, 2025 -95,000.00
Dec 31, 2024 -1.82 Mn
Dec 31, 2024 -1.82 Mn
Sep 30, 2024 1.99 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 -459,000.00
Jun 30, 2024 -459,000.00
Mar 31, 2024 -699,000.00
Mar 31, 2024 -699,000.00